Caricamento...
Membrane microdomain sphingolipids are required for anti-CD20-induced death of chronic lymphocytic leukemia B cells
BACKGROUND: Chronic lymphocytic leukemia remains incurable, despite the addition of rituximab to chemotherapy as an available means of treatment. The resistance of certain patients to this monoclonal antibody prompted us to set up in vitro studies of another CD20-specific monoclonal antibody, B1 (la...
Salvato in:
| Autori principali: | , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Ferrata Storti Foundation
2012
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3269491/ https://ncbi.nlm.nih.gov/pubmed/22058197 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2011.051938 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|